Skip to main content
Universal Drugstore logo

Why pay full price for medications?

See Prices Now

Why Is Symmetrel (Amantadine) Prescribed for Parkinson’s Disease?

Symmetrel (amantadine) is prescribed for Parkinson’s disease because it helps restore the balance of brain chemicals that control movement, reducing tremors, stiffness, and slowness of movement that characterize this condition. This FDA-approved medication works by modulating dopamine activity and blocking acetylcholine, offering relief when dopamine-producing brain cells are damaged by Parkinson’s disease.

Shop Medications

Understanding why your doctor chose Symmetrel can help you make informed decisions about your Parkinson’s treatment plan and know what to expect from this medication.

In This Article

How Does Symmetrel Work in Parkinson’s Disease?

Symmetrel works by helping to balance brain chemicals called neurotransmitters that control body movements and coordination. Specifically, it targets the imbalance between dopamine and acetylcholine that occurs in Parkinson’s disease. When Parkinson’s disease damages the brain cells that produce dopamine, it creates an imbalance where there is too little dopamine and relatively too much acetylcholine.

The medication acts on multiple pathways in the brain. It enhances dopamine activity by increasing the release of dopamine from remaining healthy brain cells and blocking its reuptake. It also blocks acetylcholine receptors, which helps counteract the excessive acetylcholine activity that contributes to Parkinson’s symptoms like muscle stiffness and tremors.

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

This dual action makes Symmetrel particularly effective at reducing the motor symptoms that define Parkinson’s disease, including the characteristic tremor at rest, muscle rigidity, and bradykinesia (slowness of movement).

When Do Doctors Prescribe Symmetrel as First-Line Treatment?

Doctors typically prescribe Symmetrel as first-line treatment for patients with early or mild Parkinson’s disease who may not yet need the more potent effects of levodopa, or for those who cannot tolerate levodopa’s side effects. This approach allows patients to manage their symptoms while potentially delaying the need for stronger medications that may have more complex side effect profiles.

The medication is particularly useful in early-stage Parkinson’s when symptoms are still manageable but affecting daily activities. Some patients respond well to Symmetrel monotherapy for several years before needing additional medications. Clinical studies have shown that about 48% of patients experience moderate to good improvement with Symmetrel, though the response is generally less dramatic than with levodopa.

Doctors may also choose Symmetrel first when patients have concerns about levodopa’s long-term complications, such as dyskinesias (involuntary movements) that can develop after years of treatment.

Why Is Symmetrel Combined with Levodopa Treatment?

Symmetrel is combined with levodopa treatment to enhance overall symptom control and potentially reduce levodopa-induced dyskinesias. This is particularly important in patients with advanced Parkinson’s disease who develop involuntary movements from long-term levodopa use. This combination approach allows doctors to optimize both medications’ benefits while minimizing individual drug doses.

When used together, Symmetrel can help smooth out the motor fluctuations that some patients experience with levodopa, such as wearing-off periods when symptoms return before the next dose. The combination may also allow for lower levodopa doses, which can be particularly beneficial for patients who experience side effects like nausea, confusion, or hallucinations with higher levodopa amounts.

Research suggests that adding Symmetrel to levodopa therapy can be especially helpful when optimal levodopa doses cannot be achieved due to side effects, providing an alternative way to improve symptom control.

What Types of Parkinson’s Symptoms Does Symmetrel Target?

Symmetrel specifically targets the motor symptoms of Parkinson’s disease, including tremor, muscle stiffness (rigidity), and slowness of movement (bradykinesia), with many patients experiencing noticeable improvement in these core symptoms within weeks of starting treatment. The medication is particularly effective at reducing the resting tremor that occurs when muscles are relaxed and the rigid, stiff feeling in arms, legs, and trunk.

Patients often report improved coordination and smoother movements when performing daily activities like writing, buttoning clothes, or walking. The medication can also help with balance and posture problems that develop as Parkinson’s progresses, though these improvements may be more subtle than the tremor and stiffness relief.

Unlike some other Parkinson’s medications, Symmetrel may have less effect on non-motor symptoms like depression, sleep problems, or cognitive changes. However, some patients report improved energy levels and reduced fatigue, which can indirectly help with mood and daily functioning.

What Are the Different Forms of Parkinsonism That Symmetrel Treats?

Symmetrel is FDA-approved to treat multiple forms of parkinsonism beyond idiopathic Parkinson’s disease, including post-encephalitic parkinsonism, arteriosclerotic parkinsonism, and parkinsonism caused by carbon monoxide poisoning. This broad approval reflects the medication’s ability to address movement problems regardless of their underlying cause, as long as they involve similar brain chemical imbalances.

The medication is also prescribed for drug-induced parkinsonism, which occurs when certain medications (particularly antipsychotics and some anti-nausea drugs) block dopamine receptors and create Parkinson-like symptoms. In these cases, Symmetrel can help restore movement function while the problematic medication is being adjusted or discontinued.

Post-encephalitic parkinsonism, which can develop years after certain viral brain infections, responds similarly to idiopathic Parkinson’s disease. The medication’s effectiveness across these different conditions demonstrates how it targets fundamental movement control mechanisms in the brain.

How Effective Is Symmetrel Compared to Other Parkinson’s Medications?

Symmetrel is generally less effective than levodopa for treating Parkinson’s symptoms but offers advantages in terms of fewer side effects and a lower risk of developing long-term motor complications like dyskinesias. Clinical studies show that while levodopa typically provides more dramatic symptom relief, Symmetrel can be sufficient for many patients, especially in early disease stages.

Research indicates that moderate to good results occur in about 48% of patients taking Symmetrel, with 31% experiencing no measurable improvement. This response rate, while lower than levodopa’s, is often acceptable given Symmetrel’s better tolerability profile and the ability to use it long-term without the motor fluctuations that can develop with levodopa.

Modern systematic reviews note that while historical use of amantadine is widespread, high-quality randomized controlled trial data supporting its effectiveness is limited by current standards. However, decades of clinical experience and patient reports continue to support its role in Parkinson’s treatment, particularly as an adjunct therapy.

What Should You Expect When Starting Symmetrel for Parkinson’s?

When starting Symmetrel for Parkinson’s disease, you can expect to begin with a low dose that gradually increases over several days to weeks, with most patients noticing some improvement in tremor and stiffness within the first few weeks of treatment. Your doctor will typically start with 100 mg once daily and may increase to 200-300 mg daily divided into two or three doses, depending on your response and tolerance.

The medication’s effects build up gradually, so patience is important during the initial weeks. Some patients notice subtle improvements in movement and coordination before obvious changes in tremor or stiffness become apparent. Keep a symptom diary to track changes, as improvements can be gradual and easier to notice when comparing week to week rather than day to day.

Side effects, when they occur, are typically mild and may include difficulty sleeping, dry mouth, constipation, or ankle swelling. These often improve as your body adjusts to the medication. If you experience more concerning symptoms like confusion, hallucinations, or severe mood changes, contact your doctor immediately as the dose may need adjustment.

Who Should Not Take Symmetrel for Parkinson’s Disease?

Patients with severe kidney disease, untreated narrow-angle glaucoma, or a history of serious psychiatric disorders should generally avoid Symmetrel, as the medication can worsen these conditions or interact dangerously with the underlying disease process. The drug is eliminated primarily through the kidneys, so reduced kidney function can lead to dangerous accumulation of the medication in the body.

Elderly patients require special consideration, as they may be more sensitive to Symmetrel’s effects on the brain and more likely to experience confusion, hallucinations, or balance problems. Your doctor will carefully weigh the benefits against risks and may recommend starting with lower doses or more frequent monitoring.

Patients taking certain other medications, particularly those that affect brain chemistry or kidney function, may need dose adjustments or alternative treatments. Always provide your doctor with a complete list of all medications, supplements, and herbal products you take before starting Symmetrel.

References

Related Conditions